KADIMA IN THE NEWS
Kadima and Dr. Feifel’s groundbreaking work on Ketamine and TMS therapy has garnered the attention of major news outlets such as The New York Times, TIME Magazine, The Washington Post, NPR, Popular Science, NBC, Scientific American, and USA Today, among others.
“Barbara Reiger, who’s 59 and lives in San Diego, says she tried nearly everything to lift her out of the depression that had plagued her since childhood and sometimes rendered her suicidal.When she learned about ketamine in 2015, she decided to try it at a ketamine clinic in her hometown. Since ketamine is FDA-approved as an anesthetic, physicians can legally prescribe it off-label for any condition they believe it may help, including depression.Ketamine trips are known to help people disconnect from their bodies and their thoughts, and it worked that way for Reiger. After her first trip, she remembers feeling better than she had for years. “I immediately felt relief … a lightness of the depression kind of lifting,” says Reiger. And it all happened in less than an hour.”
Read the full story on Time Magazine
In an interview with Dr. Sanjay Gupta on CNN’s Chasing Life podcast, Dr. David Feifel, a leading expert in ketamine therapy and founder of Kadima Neuropsychiatry, discussed the rising use of ketamine in mental health treatment. He addressed both the promise and the challenges surrounding ketamine, especially following the tragic death of actor Matthew Perry, who was using ketamine for depression without medical supervision before his passing.
Read the full story on CNN
Kadima and Dr. Feifel featured in the news (click for full article)
Kadima featured on broadcasted news
Leave your details and we will contact you: